Market Closed -
Bombay S.E.
06:00:50 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
958
INR
|
+5.92%
|
|
+5.09%
|
-6.85%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
68,905
|
64,519
|
33,559
|
78,150
|
176,230
|
116,551
|
Enterprise Value (EV)
1 |
75,082
|
76,789
|
50,982
|
80,209
|
176,935
|
124,520
|
P/E ratio
|
10.3
x
|
7.25
x
|
4.68
x
|
11.6
x
|
16.5
x
|
12.8
x
|
Yield
|
1.93%
|
2.37%
|
3.81%
|
1.86%
|
1.3%
|
1.87%
|
Capitalization / Revenue
|
1
x
|
0.83
x
|
0.43
x
|
0.94
x
|
1.83
x
|
1.01
x
|
EV / Revenue
|
1.09
x
|
0.99
x
|
0.66
x
|
0.97
x
|
1.84
x
|
1.08
x
|
EV / EBITDA
|
7.25
x
|
5.62
x
|
4.29
x
|
7.19
x
|
10
x
|
7.86
x
|
EV / FCF
|
32.6
x
|
-19.6
x
|
-11
x
|
5.99
x
|
761
x
|
-21.2
x
|
FCF Yield
|
3.07%
|
-5.11%
|
-9.12%
|
16.7%
|
0.13%
|
-4.72%
|
Price to Book
|
2.27
x
|
1.83
x
|
0.83
x
|
1.68
x
|
3.2
x
|
1.88
x
|
Nbr of stocks (in thousands)
|
162,416
|
155,842
|
155,942
|
155,942
|
155,942
|
155,942
|
Reference price
2 |
424.2
|
414.0
|
215.2
|
501.2
|
1,130
|
747.4
|
Announcement Date
|
8/2/18
|
6/27/19
|
6/28/20
|
6/25/21
|
6/24/22
|
6/29/23
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
69,004
|
77,711
|
77,671
|
83,082
|
96,274
|
115,470
|
EBITDA
1 |
10,362
|
13,674
|
11,874
|
11,152
|
17,644
|
15,841
|
EBIT
1 |
9,044
|
12,197
|
9,976
|
9,113
|
15,497
|
13,472
|
Operating Margin
|
13.11%
|
15.69%
|
12.84%
|
10.97%
|
16.1%
|
11.67%
|
Earnings before Tax (EBT)
1 |
8,674
|
11,820
|
9,000
|
8,909
|
15,662
|
14,131
|
Net income
1 |
6,696
|
9,055
|
7,167
|
6,733
|
10,674
|
9,108
|
Net margin
|
9.7%
|
11.65%
|
9.23%
|
8.1%
|
11.09%
|
7.89%
|
EPS
2 |
41.22
|
57.09
|
45.96
|
43.17
|
68.45
|
58.41
|
Free Cash Flow
1 |
2,303
|
-3,921
|
-4,651
|
13,388
|
232.6
|
-5,875
|
FCF margin
|
3.34%
|
-5.05%
|
-5.99%
|
16.11%
|
0.24%
|
-5.09%
|
FCF Conversion (EBITDA)
|
22.22%
|
-
|
-
|
120.05%
|
1.32%
|
-
|
FCF Conversion (Net income)
|
34.39%
|
-
|
-
|
198.84%
|
2.18%
|
-
|
Dividend per Share
2 |
8.200
|
9.800
|
8.200
|
9.300
|
14.70
|
14.00
|
Announcement Date
|
8/2/18
|
6/27/19
|
6/28/20
|
6/25/21
|
6/24/22
|
6/29/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
6,177
|
12,270
|
17,423
|
2,058
|
705
|
7,969
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.5961
x
|
0.8973
x
|
1.467
x
|
0.1846
x
|
0.04
x
|
0.5031
x
|
Free Cash Flow
1 |
2,303
|
-3,921
|
-4,651
|
13,388
|
233
|
-5,875
|
ROE (net income / shareholders' equity)
|
24%
|
27.5%
|
19%
|
15.5%
|
21%
|
15.6%
|
ROA (Net income/ Total Assets)
|
10.1%
|
11.9%
|
8.16%
|
7.15%
|
11.3%
|
8.38%
|
Assets
1 |
66,486
|
75,953
|
87,779
|
94,131
|
94,561
|
108,682
|
Book Value Per Share
2 |
187.0
|
226.0
|
260.0
|
298.0
|
353.0
|
397.0
|
Cash Flow per Share
2 |
8.230
|
24.50
|
34.80
|
55.80
|
59.70
|
28.90
|
Capex
1 |
3,797
|
8,509
|
5,935
|
2,514
|
7,680
|
17,974
|
Capex / Sales
|
5.5%
|
10.95%
|
7.64%
|
3.03%
|
7.98%
|
15.57%
|
Announcement Date
|
8/2/18
|
6/27/19
|
6/28/20
|
6/25/21
|
6/24/22
|
6/29/23
|
|
1st Jan change
|
Capi.
|
---|
| -0.19% | 74.89B | | +0.09% | 46.52B | | -4.19% | 30.82B | | +9.85% | 18.19B | | -10.05% | 11.54B | | +6.39% | 11.24B | | -8.09% | 9.73B | | +2.79% | 9.4B | | +6.35% | 9.37B |
Diversified Chemicals
|